TY - JOUR
T1 - The impact of hypo-attenuated leaflet thickening on haemodynamic valve deterioration following transcatheter aortic valve replacement
AU - Rashid, Hashrul N.
AU - Michail, Michael
AU - Ramnarain, Jaineel
AU - Nasis, Arthur
AU - Nicholls, Stephen J.
AU - Cameron, James D.
AU - Gooley, Robert P.
N1 - Funding Information:
Dr Hashrul N Rashid and this research is supported by the Postgraduate Scholarship (Reference No. APP 1191131) from the National Health and Medical Research Council (NHMRC) , Health Professional Scholarship (Reference No. 102452) from the National Heart Foundation of Australia and the Kincaid-Smith Scholarship from the Royal Australasian College of Physicians (RACP) and Postdoctoral Fellowship (Reference 105817) from the National Heart Foundation of Australia and Collaboration & Exchange Award (Reference 106369) from the National Heart Foundation of Australia . All the funders were not involved in the design, data collection or data interpretation of this manuscript.
Publisher Copyright:
© 2021
PY - 2022/3
Y1 - 2022/3
N2 - Background: Hypo-attenuated leaflet thickening (HALT) may occur following transcatheter aortic valve replacement (TAVR), however, it remains unclear if HALT is a predictor of haemodynamic valve deterioration (HVD). Aim: To determine the impact of HALT on the occurrence of HVD. Methods: We prospectively evaluated 186 patients for the presence of HALT at a median of 6 weeks following TAVR (Interquartile-range [IQR] 4–12 weeks). HALT depth and area were measured. HVD encompassed any of the following: mean gradient ≥20 mmHg with an increase in gradient ≥10 mmHg from baseline, Doppler velocity index reduction ≥0.1 or new moderate-to-severe valvular regurgitation. Routine echocardiograms at discharge, one month and annually, were assessed by echo-cardiologists that were blinded to the HALT status. Results: LT prevalence was 17.7% (33/186). HVD was present in 8.6% (16/186) at a median follow-up of 2 years (IQR 1–3); two required valve re-intervention and five required anticoagulation. HALT was the only independent predictor of HVD on multivariate analysis (OR 33.3, 95%CI 7.4–125). Patients with HALT were more likely to develop HVD, require repeat valve intervention and have higher trans-valvular gradients at up to 3-year follow-up. Patients with HALT had a median cumulative thickness of 2.9 mm (IQR 1.9–4.7) and area of 64.2 mm2 (IQR 40.9–91.6). Thresholds for HALT in predicting HVD were a cumulative depth of 2.4 mm (Specificity 94.1%, Sensitivity 75.0%, AUC = 0.87) and cumulative area of 28 mm2 (Specificity 92.2%, Sensitivity 81.3%, AUC = 0.86). Conclusion: HALT is an independent predictor of HVD, which exhibits specific depth and area thresholds to predict HVD. CT following TAVR may determine patients at risk of HVD.
AB - Background: Hypo-attenuated leaflet thickening (HALT) may occur following transcatheter aortic valve replacement (TAVR), however, it remains unclear if HALT is a predictor of haemodynamic valve deterioration (HVD). Aim: To determine the impact of HALT on the occurrence of HVD. Methods: We prospectively evaluated 186 patients for the presence of HALT at a median of 6 weeks following TAVR (Interquartile-range [IQR] 4–12 weeks). HALT depth and area were measured. HVD encompassed any of the following: mean gradient ≥20 mmHg with an increase in gradient ≥10 mmHg from baseline, Doppler velocity index reduction ≥0.1 or new moderate-to-severe valvular regurgitation. Routine echocardiograms at discharge, one month and annually, were assessed by echo-cardiologists that were blinded to the HALT status. Results: LT prevalence was 17.7% (33/186). HVD was present in 8.6% (16/186) at a median follow-up of 2 years (IQR 1–3); two required valve re-intervention and five required anticoagulation. HALT was the only independent predictor of HVD on multivariate analysis (OR 33.3, 95%CI 7.4–125). Patients with HALT were more likely to develop HVD, require repeat valve intervention and have higher trans-valvular gradients at up to 3-year follow-up. Patients with HALT had a median cumulative thickness of 2.9 mm (IQR 1.9–4.7) and area of 64.2 mm2 (IQR 40.9–91.6). Thresholds for HALT in predicting HVD were a cumulative depth of 2.4 mm (Specificity 94.1%, Sensitivity 75.0%, AUC = 0.87) and cumulative area of 28 mm2 (Specificity 92.2%, Sensitivity 81.3%, AUC = 0.86). Conclusion: HALT is an independent predictor of HVD, which exhibits specific depth and area thresholds to predict HVD. CT following TAVR may determine patients at risk of HVD.
KW - Haemodynamic valve deterioration
KW - Leaflet thickening
KW - Leaflet thrombosis
KW - Reduced leaflet motion
KW - TAVI
KW - TAVR
UR - http://www.scopus.com/inward/record.url?scp=85120161317&partnerID=8YFLogxK
U2 - 10.1016/j.jcct.2021.11.013
DO - 10.1016/j.jcct.2021.11.013
M3 - Article
C2 - 34852974
AN - SCOPUS:85120161317
SN - 1934-5925
VL - 16
SP - 168
EP - 173
JO - Journal of Cardiovascular Computed Tomography
JF - Journal of Cardiovascular Computed Tomography
IS - 2
ER -